By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix reported after the close of the market on Wednesday that its first-quarter revenues slid 8 percent, but the company recorded a modest profit.

For the three months ended March 31, the Santa Clara, Calif.-based microarray company recorded revenues of $73.7 million, down from $80.2 million a year ago and missing analyst estimates of $75.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.